The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFranchise Brands Regulatory News (FRAN)

Share Price Information for Franchise Brands (FRAN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 196.50
Bid: 196.00
Ask: 197.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.51%)
Open: 196.50
High: 196.50
Low: 196.00
Prev. Close: 196.50
FRAN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Grant of options and award of SARs

11 Mar 2022 11:25

RNS Number : 5195E
Franchise Brands PLC
11 March 2022
 

11 March 2022

 

Franchise Brands PLC

("Franchise Brands", the "Group" or the "Company")

 

Grant of options and award of SARs

 

Franchise Brands (AIM: FRAN), a multi-brand international franchise business, announces that its Remuneration Committee yesterday approved the grant of options and award of share acquisition rights ("SARs") to employees and directors.

 

A total of 922,667 CSOP (Company Share Option Plan) options and 1,236,333 non-tax advantaged (non-approved) options, all with an exercise price of £1.50 per share (being the closing mid-market price of an ordinary share on 9 March 2022), have been granted.

 

In addition, 1,177,000 SARs have been awarded to employees who are non-UK resident, with a grant price of £1.50 each. The SARs are conditional bonuses whose value will be calculated by reference to the amount by which the price of the Company's ordinary shares has risen above the grant price at the date of exercise, thus providing holders of SARs the same reward value as if the SARs were share options. The qualifying conditions and timing of vesting are identical to those within the share option schemes for UK employees. All SARs are settled in cash when exercised. 

 

The CSOP options and non-approved options granted and the SARs awarded expire on 9 March 2032.

 

The CSOP options, non-approved options and SARs are all subject to satisfaction of the following performance conditions:

 

1) as to 20 per cent. after reported fully diluted adjusted earnings per share ("EPS") achieves compound annual growth of 8 per cent. over each of the next three financial years;

 

2) as to 100 per cent. after reported fully diluted adjusted EPS achieves compound annual growth of 15 per cent. over each of the next three financial years; and

 

3) between 20 per cent. to 100 per cent. of their options on a sliding scale basis on EPS growth between the targets in 1) and 2) above.

 

Certain directors of the Company have been granted options or awarded SARs, details of which are set out below.

 

Director

Number of non-approved options granted

Number of SARs awarded

Total

Brian Hogan

360,000

360,000

Peter Molloy

150,000

 

150,000

Colin Rees

90,000

 

90,000

Tim Harris

60,000

 

60,000

Julia Choudhury

60,000

 

60,000

 

 

The notifications below, which have been made in accordance with the requirements of the UK Market Abuse Regulation, provides further detail.

 

Enquiries:

 

Franchise Brands plc

+ 44 (0) 1625 813231

Stephen Hemsley, Executive Chairman

 

Brian Hogan, Chief Financial Officer

 

Julia Choudhury, Corporate Development Director

 

 

 

Allenby Capital Limited (Nominated Adviser and Joint Broker)

+44 (0) 20 3328 5656

Jeremy Porter / Liz Kirchner (Corporate Finance)

Amrit Nahal (Sales and Corporate Broking)

 

 

 

Dowgate Capital Limited (Joint Broker)

+44 (0) 20 3903 7715

James Serjeant / Russell Cook / Nicholas Chambers

 

 

 

MHP Communications (Financial PR)

+44 (0) 20 3128 8100

Katie Hunt

+44 (0) 7884 494112

 

franchisebrands@mhpc.com

 

 

 Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them. 

 

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Directors:

 

Brian Hogan

Peter Molloy

Colin Rees

Tim Harris

Julia Choudhury

2

Reason for the notification

a)

Position/status

Directors of Franchise Brands plc

b)

 

Initial notification /Amendment

Initial notification

3

 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Franchise Brands plc

b)

LEI

213800CFRX6CJ8LCKN37

4

 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

 

Description of the financial instrument, type of instrument

Identification code

ordinary shares of 0.5p each in Franchise Brands plc

Identification code (ISIN) for Franchise Brands plc ordinary shares: GB00BD6P7Y24

b)

Nature of the transaction

Grant of CSOP options, non-approved options and award of SARs

c)

Price(s) and volume(s)

Exercise price: £1.50 

 

Director

Number of non-approved options granted

Number of SARs awarded

Total

Brian Hogan

360,000

360,000

Peter Molloy

150,000

 

150,000

Colin Rees

90,000

 

90,000

Tim Harris

60,000

 

60,000

Julia Choudhury

60,000

 

60,000

 

 

d)

Aggregated information

- Aggregated volume

- Price

n/a

e)

Date of the transaction

10 March 2022

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHFLFFLVFILLIF
Date   Source Headline
4th Apr 20243:02 pmRNSHolding(s) in Company
20th Feb 20242:45 pmRNSCapital Markets Day
18th Jan 20247:00 amRNSCapital Markets Day
18th Jan 20247:00 amRNSTrading Update
16th Jan 20245:12 pmRNSHolding(s) in Company
21st Nov 20237:00 amRNSInvestor presentation
15th Nov 20233:11 pmRNSHolding(s) in Company
25th Oct 20237:00 amRNSQ3 Trading Update
4th Sep 20237:00 amRNSBoard and management update
4th Aug 20237:00 amRNSDirector/PDMR Shareholding and Grant of Options
27th Jul 20237:01 amRNSAppointment of Chief Financial Officer
27th Jul 20237:00 amRNSInterim Results
25th Jul 20231:51 pmRNSInvestor Presentation via Investor Meet Company
5th Jul 20237:00 amRNSNotice of Interim Results
26th Jun 20237:00 amRNSShare Purchase Programme
1st Jun 20237:00 amRNSDirector/PDMR Shareholding
18th May 202310:10 amRNSHolding(s) in Company
10th May 20235:54 pmRNSGrant of options & director holdings
4th May 20237:00 amRNSInvestor Presentation
28th Apr 20235:00 pmRNSTotal Voting Rights
25th Apr 20234:09 pmRNSHolding(s) in Company
24th Apr 20231:55 pmRNSHolding(s) in Company
20th Apr 20239:33 amRNSResult of GM, Completion of Acquisition and TVR
18th Apr 20231:56 pmRNSResult of AGM
18th Apr 20237:00 amRNSAGM Statement and Trading Update
14th Apr 202312:10 pmRNSDirector/PDMR Shareholding
4th Apr 202312:08 pmRNSResult of Placing and Notice of GM
3rd Apr 20235:52 pmRNSProposed Acquisition and Launch of ABB
20th Mar 20237:00 amRNSPosting of Annual Report and Notice of AGM
13th Mar 202312:24 pmRNSHolding(s) in Company
10th Mar 20237:00 amRNSRule 19.6(c) confirmation
9th Mar 20234:54 pmRNSDividend Declaration and AGM date
9th Mar 20237:00 amRNSFinal Results
8th Mar 20235:20 pmRNSHolding(s) in Company
23rd Feb 20237:00 amRNSAnnual Results Presentation
22nd Feb 20237:00 amRNSAppointment of Joint Corporate Broker
25th Jan 20237:00 amRNSNotice of Results
23rd Jan 20237:00 amRNSNotice of Electronic Communications
13th Jan 20237:00 amRNSCapital Markets Day
12th Jan 20237:00 amRNSTrading Update
23rd Dec 20227:00 amRNSShare Purchase Programme
30th Nov 20225:00 pmRNSTotal Voting Rights
30th Nov 20224:40 pmRNSSecond Price Monitoring Extn
30th Nov 20224:35 pmRNSPrice Monitoring Extension
8th Nov 20227:00 amRNSExercise of share options, PDMR notification & TVR
1st Nov 20221:41 pmEQSFranchise Brands benefiting from strong contributions by Filta North America and Metro Rod
27th Oct 20227:00 amRNSQ3 Trading Update
3rd Oct 20227:00 amRNSAppointment of Interim CFO and grant of options
12th Sep 20227:00 amRNSAppointment of Non-Executive Director
26th Jul 20227:00 amRNSInterim Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.